From The Industry Experts
-
How Health Information Technology Is Transforming Human Lives
5/15/2024
Here, the authors take a closer look at how these advancements are not just revolutionizing healthcare but also instilling hope for a brighter and healthier future.
-
Earlier Disease Detection Study Utilizes EDC
5/15/2024
Leveraging hyperspectral imaging and AI-driven analysis, Optina Diagnostics aims to revolutionize Alzheimer's diagnosis, offering hope for earlier intervention and improved outcomes.
-
Measuring The True Patient Experience With ePRO
5/15/2024
Utilizing the insights covered in this article can inform the design and implementation of cancer trials, ultimately contributing to improved patient care and treatment outcomes.
-
ISR Report Sheds Light On eCOA/ePRO Market Dynamics
5/15/2024
This comprehensive overview highlights the critical role these platforms play in modern clinical research, emphasizing their impact on data integrity and trial efficiency.
-
Evaluating ‘Bother’ As A Component Of Patient-Reported Outcomes
5/15/2024
Learn how incorporating "bother" as a patient-reported outcome metric aligns research with real-world experiences and drug development with patient needs.
-
Webinar Recap: How EDC Can Support Modern Clinical Trials
5/15/2024
Gain insights from our recent webinar focused on the critical role EDC systems play in supporting modern working practices and innovative trial designs, structured around four key themes.
-
Navigating Audit Trail Data Regulations And Accessibility Changes
5/15/2024
Data is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.
-
Top Clinical Research Themes And Trends
5/15/2024
We analyzed web traffic, content downloads, social media engagement, webinar attendance, and other metrics to determine the themes that caught your attention and aligned with broader industry trends.
-
Finding The Right Patients For Ketamine Clinical Trials
5/15/2024
Revitalist CEO Kathryn Walker has discusses which patients are well-suited for trials exploring ketamine therapies, especially those for treating mental health conditions.
-
RBQM: The Connective Tissue For Data Quality
5/14/2024
Explore the role of risk-based quality management (RBQM) in clinical trials and how it enhances efficiency, ensures data integrity, and mitigates risks with advanced analytics and proactive monitoring